SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-008854
Filing Date
2019-10-08
Accepted
2019-10-08 16:04:59
Documents
1
Period of Report
2019-10-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 50521
  Complete submission text file 0001558370-19-008854.txt   51640
Mailing Address P.O. BOX 130235 ANN ARBOR MI 48113
Business Address P.O. BOX 130235 ANN ARBOR MI 48113 734-245-1700
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 191142781
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences